ELITE PHARMACEUTICALS INC /NV/ Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Elite Pharmaceuticals Inc /Nv/ quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Elite Pharmaceuticals Inc /Nv/ Return On Assets for the quarter ending September 30, 2024 was -7.64 %, a 123% decline year-over-year.
  • Elite Pharmaceuticals Inc /Nv/ annual Return On Assets for 2023 was 41.9 %, a 275% increase from 2022.
  • Elite Pharmaceuticals Inc /Nv/ annual Return On Assets for 2022 was 11.2 %, a 65.4% decline from 2021.
  • Elite Pharmaceuticals Inc /Nv/ annual Return On Assets for 2021 was 32.3 %, a 53.6% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 41.9 +30.7 +275% Apr 1, 2023 Mar 31, 2024
2022 11.2 -21.1 -65.4% Apr 1, 2022 Mar 31, 2023
2021 32.3 +11.3 +53.6% Apr 1, 2021 Mar 31, 2022
2020 21 +29.4 Apr 1, 2020 Mar 31, 2021
2019 -8.41 +20.4 +70.8% Apr 1, 2019 Mar 31, 2020
2018 -28.8 -18.2 -171% Apr 1, 2018 Mar 31, 2019
2017 -10.6 -23.6 -182% Apr 1, 2017 Mar 31, 2018
2016 13 +15.7 Apr 1, 2016 Mar 31, 2017
2015 -2.75 -32.4 -109% Apr 1, 2015 Mar 31, 2016
2014 29.7 +425 Apr 1, 2014 Mar 31, 2015
2013 -395 -409 -2955% Apr 1, 2013 Mar 31, 2014
2012 13.9 Apr 1, 2012 Mar 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.